top of page

OUR TEAM

We’re a small, dedicated team built on respect, clear communication, and uncompromising Quality. Innovation is how we continuously improve, and by working inclusively and drawing on diverse perspectives, we see what others miss.

 

At NeoVac, complex challenges become reliable outcomes.

OUR FOUNDERS

Vice President for R&D at Tel Aviv University

  • First to show systemic, cell-specific delivery of mRNA in animals

  • First to show high efficiency therapeutic genome editing in cancer

  • First to develop bacterial mRNA vaccine​​

 

Prolific Founder:

  • Precision Nanosystems (acquired by Danaher)

  • Licensed IP to Genentech, Merck, BioNTech and many other companies.

  • International Member, National Academy of Engineering (USA)

  • Fellow of the United States National Academy of Inventors (NAI)

 Director of Jenner Institute at University of Oxford

  • Co-inventor of the AstraZeneca COVID-19 vaccine

  • Led more than 80 high-profile vaccine clinical trials, including for malaria, Ebola, MERS, and COVID-19

  • Key advisor to international health organisations, including the WHO

​

 

Prolific Founder:

  • Co-Founder of Barinthus (formerly Vaccitech)

  • Co-Founder of Vaccines Manufacturing and Innovation Centre (VMIC)

MANAGEMENT TEAM

OUR TEAM

bottom of page